Free Trial

Simplify Propel Opportunities ETF Rating

$17.50 -0.22 (-1.24%)
As of 04:10 PM Eastern

Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

SURI Aggregate Rating

Moderate Buy
2.68

Holdings in SURI have an aggregate rating of Moderate Buy based on 135 analyst ratings issued in the past year covering 17 companies (91.4% of the portfolio).

SURI Aggregate Price Target

$17.50
High Prediction$17.50
Average Prediction$17.50
Low Prediction$17.50

Holdings in SURI have an aggregate price target of $17.50 and a range of $17.50 to $17.50 covering 17 companies (91.4% of the portfolio).

SURI Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
Moderate Buy
7 Moderate Buy rating(s)
Hold
2 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Simplify Propel Opportunities ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 17 SURI Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
33.67%
Plains GP Holdings, L.P. stock logo
PAGP
Plains GP
$21.68
-0.7%
2.0112 of 5 stars
2.40$20.60 -5.0%10Positive News
15.46%
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$51.84
+2.5%
4.3991 of 5 stars
3.00$75.86 46.3%9Insider Trade
9.76%
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$336.23
-4.2%
3.3133 of 5 stars
2.69$351.67 4.6%13
5.15%
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$31.12
-4.3%
1.613 of 5 stars
3.00$65.80 111.4%10
5.11%
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
$5.67
+2.3%
2.5178 of 5 stars
2.80$23.00 305.6%5Gap Up
5.00%
Pathward Financial, Inc. stock logo
CASH
Pathward Financial
$77.49
-3.0%
2.5729 of 5 stars
2.50$90.50 16.8%2
3.37%
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
$2.17
-0.9%
2.4638 of 5 stars
3.00$11.25 418.4%4
2.83%
Abeona Therapeutics Inc stock logo
ABEO
Abeona Therapeutics
$5.78
-0.7%
4.22 of 5 stars
3.00$18.00 211.4%3Analyst Forecast
News Coverage
2.69%
Applied Therapeutics, Inc. stock logo
APLT
Applied Therapeutics
$0.53
-6.2%
4.6939 of 5 stars
2.57$6.10 1,050.9%7
2.13%
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
$16.38
+2.4%
3.7342 of 5 stars
2.90$36.20 121.0%10
1.51%
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$36.81
-1.6%
2.3349 of 5 stars
2.88$55.06 49.6%17News Coverage
1.18%
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
$7.68
-1.9%
1.8653 of 5 stars
3.25$21.57 180.9%8
0.98%
Athira Pharma, Inc. stock logo
ATHA
Athira Pharma
$0.43
-3.2%
2.9149 of 5 stars
2.00$13.83 3,086.7%4
0.89%
Achieve Life Sciences, Inc. stock logo
ACHV
Achieve Life Sciences
$3.17
-1.6%
2.1745 of 5 stars
3.33$14.80 366.9%6
0.79%
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
$8.25
+1.2%
4.3925 of 5 stars
2.83$27.13 228.9%12
0.72%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$14.88
-4.2%
3.0316 of 5 stars
3.00$22.25 49.5%4
0.15%
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
$5.97
-3.1%
3.5023 of 5 stars
3.00$64.44 979.8%11

This page (NYSEARCA:SURI) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners